Log In
Print this Print this

Prostate Cancer Index (PCI) test

  Manage Alerts
Collapse Summary General Information
Company bioMerieux S.A.
DescriptionMolecular prostate cancer recurrence assay based on the expression of 32 genes
Molecular Target Prostate-specific antigen (KLK3) (PSA)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsPredict risk of prostate cancer recurrence following radical prostatectomy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today